New pediatric brand dedicated to helping children and young adults
with bone fractures and deformities to be unveiled at EPOSNA annual
meeting in Barcelona
LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical
device company, today announced the launch of JuniOrtho™, a
new pediatric brand focused on solutions for children and young adults
with orthopedic and congenital deformities. The Company will unveil
"JuniOrtho, paediatrics powered by Orthofix" at the EPOSNA
annual meeting in Barcelona on May 3, 2017.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20170501005247/en/
Designed to be the link between surgeons, parents and children, Orthofix
is bringing products and resources together under the JuniOrtho brand to
give medical professionals and families alike the best in pediatric
orthopedic solutions.
"With a long history of developing innovative and cutting edge extremity
fixation technologies, Orthofix has now brought all of our pediatric
expertise and products together under the JuniOrtho banner," said Davide
Bianchi, President of the Extremity Fixation strategic business unit.
"This launch represents much more than our products; it's also a
commitment to be a resource for surgeons and the parents and caregivers
of pediatric patients before, during and after surgery."
As part of the JuniOrtho brand launch, the company has developed new
resources to help educate families and enable them to make informed
decisions regarding their child's surgery. These include:
-
JuniOrtho website - www.juniortho.club
featuring tools and resources for families and medical professionals
-
www.limbhealing.com
- educational website dedicated to providing information about
deformity correction featuring patient stories and useful resources
-
Age appropriate apps, games, coloring sheets, comic books and
literature to help young patients understand and be comfortable with
their orthopedic procedures
"For parents, the decision to have surgery for a child is a big one.
Typically, they come to the surgery consultation after doing some online
research regarding their child's condition and of course they have a lot
of questions," said Christopher Iobst, Director, Center for Limb
Lengthening and Reconstruction, Nationwide Children's Hospital and
Clinical Associate Professor of Orthopedic Surgery at The Ohio State
University College of Medicine. "Having patient resources such as
websites, activity sheets and games is a great way to provide children
and their parents with additional insight."
The JuniOrtho team at Orthofix boasts an unrivalled level of in-house
expertise in the field of pediatric orthopedics that began in the late
1970s in Verona, Italy with orthopedic researcher Giovanni De Bastiani.
He established the concept of "dynamization," based on the natural
ability of the bone to repair itself. De Bastiani developed a modular
system of external axial frame devices that could be fitted to a bone,
allowing micromovement at the fracture site to stimulate bone healing.
Along with a few colleagues, De Bastiani founded Orthofix in 1980 in
order to continue the development of these devices.
The first product commercialized by the Company was the Limb Lengthener,
a pediatric extremity fixation product to correct bone deformities
(lengthening). Since launching the first pediatric products in the early
'80s, Orthofix has brought to market more than 35 devices to help adults
and children suffering from deformities and trauma to bones of the
extremities.
Today, Orthofix's JuniOrtho solutions consist of a wide-range of
products designed for children and young adults. Flagship products in
this family include the TL
HEX™ TrueLok Hexapod system and the Guided
Growth™ plating systems that are available in more than
70 countries around the world.
Orthofix invites those attending the EPOSNA Annual Meeting to visit
Booth #17 to learn more about JuniOrtho products and resources.
About Orthofix
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, TX, the company has
four strategic business units that include BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the company's sales representatives, distributors and subsidiaries.
In addition, Orthofix is collaborating on research and development
activities with leading clinical organizations such as Brown University,
Sinai Hospital of Baltimore, Cleveland Clinic, Texas Scottish Rite
Hospital for Children and the Musculoskeletal Transplant Foundation. For
more information, please visit www.orthofix.com.
Forward-Looking Statements
This communication contains certain forward-looking statements under the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements, which may include, but are not limited to, statements
concerning the projections, financial condition, results of operations
and businesses of Orthofix and its subsidiaries, are based on
management's current expectations and estimates and involve risks and
uncertainties that could cause actual results or outcomes to differ
materially from those contemplated by the forward-looking statements.
The forward-looking statements in this release do not constitute
guarantees or promises of future performance. Factors that could cause
or contribute to such differences may include, but are not limited to,
risks described in the "Risk Factors" section of our Annual Report on
Form 10-K for the fiscal year ended December 31, 2016, as well as in
other reports that we file in the future. Existing and prospective
investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof. The
Company undertakes no obligation to update or revise the information
contained in this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170501005247/en/
Orthofix, Inc.
Investor Relations:
Mark Quick, 214-937-2924
markquick@orthofix.com
or
Media
Relations:
Denise Landry, 214-937-2529
deniselandry@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media